Abstract

The neuromodulatory subcortical nuclei within the isodendritic core (IdC) are the earliest sites of tauopathy in Alzheimer’s disease (AD). They project broadly throughout the brain’s white matter. We investigated the relationship between IdC microstructure and whole-brain white matter microstructure to better understand early neuropathological changes in AD. Using multiparametric quantitative magnetic resonance imaging we observed two covariance patterns between IdC and white matter microstructure in 133 cognitively unimpaired older adults (age 67.9 ± 5.3 years) with familial risk for AD. IdC integrity related to 1) whole-brain neurite density, and 2) neurite orientation dispersion in white matter tracts known to be affected early in AD. Pattern 2 was associated with CSF concentration of phosphorylated-tau, indicating AD specificity. Apolipoprotein-E4 carriers expressed both patterns more strongly than non-carriers. IdC microstructure variation is reflected in white matter, particularly in AD-affected tracts, highlighting an early mechanism of pathological development.

The isodendritic core is a group of neuromodulatory nuclei with diffuse projections. Here the authors describe associations between the microstructural integrity of the isodendritic core and whole-brain white matter in humans, and its relationship to Apolipoprotein-E4 carrier status.

Details

Title
Neuromodulatory subcortical nucleus integrity is associated with white matter microstructure, tauopathy and APOE status
Author
Wearn, Alfie 1   VIAFID ORCID Logo  ; Tremblay, Stéfanie A. 2 ; Tardif, Christine L. 3 ; Leppert, Ilana R. 4 ; Gauthier, Claudine J. 2 ; Baracchini, Giulia 1   VIAFID ORCID Logo  ; Hughes, Colleen 1 ; Hewan, Patrick 5 ; Tremblay-Mercier, Jennifer 6 ; Rosa-Neto, Pedro 7   VIAFID ORCID Logo  ; Poirier, Judes 8   VIAFID ORCID Logo  ; Villeneuve, Sylvia 9   VIAFID ORCID Logo  ; Schmitz, Taylor W. 10   VIAFID ORCID Logo  ; Turner, Gary R. 5   VIAFID ORCID Logo  ; Spreng, R. Nathan 11   VIAFID ORCID Logo 

 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
 Concordia University, Department of Physics, Montreal, Canada (GRID:grid.410319.e) (ISNI:0000 0004 1936 8630); Montreal Heart Institute, Montreal, Canada (GRID:grid.482476.b) (ISNI:0000 0000 8995 9090); Concordia University, School of Health, Montreal, Canada (GRID:grid.410319.e) (ISNI:0000 0004 1936 8630) 
 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Biomedical Engineering, McGill, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
 York University, Department of Psychology, Toronto, Canada (GRID:grid.21100.32) (ISNI:0000 0004 1936 9430) 
 Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268) 
 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268) 
 Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268); McGill University, Department of Psychiatry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
 McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268); McGill University, Department of Psychiatry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
10  Western University, Department of Physiology & Pharmacology, Western Institute for Neuroscience, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884) 
11  McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268); McGill University, Department of Psychiatry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
Pages
4706
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3063931932
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.